Delivery Order SPE2DB20D9331-SPE2DB23FL1M2
Award Date
8/30/23
Potential Completion Date
9/21/23
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,210.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through December 20, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award (SPE2DX15D9168|SPE2DX24F6XCQ) was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $4,013.70 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML and does not have a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (4600082013) with the DLA, worth up to $4,999,999 through 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,249.10 firm fixed-price delivery order is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of November 16, 2022. DMS Pharmaceutical Group is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,210.96, is for the supply of a pharmaceutical product, Tissueblue 0.025% Syringe 0.5ML, to support the recurring medical supply needs of military health facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,136.10, is for the supply of a specific pharmaceutical product - TISSUEBLUE 0.025% SYRINGE 0.5ML. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $4,816.44 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of Department of Defense (DoD) healthcare facilities worldwide. This delivery order,...
This federal contract award, valued at $3,210.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% tissueblue solution, a medical product used in various healthcare applications. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
This federal contract award, identified as SPE2DB20D9759|SPE2DB25FD5KH, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,691.16 firm fixed-price delivery order is for the supply of 4567359727 ! VISIONBLUE 0.06% SYRINGE 0.5ML, with a performance period through January 29, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...